In the IRE1α–X-box binding protein 1 (XBP1) axis, knockdown of XBP1 has been shown to inhibit the growth of estrogen receptor 1 (ESR1)-positive breast cancer cells, demonstrating its pro-survival role in hormone-responsive tumors [19]. Here, XBP1 is linked to breast carcinoma.